We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Alliance to Develop Blood Test for Ovarian Cancer

By HospiMedica staff writers
Posted on 30 Jun 2004
A collaboration to advance the final development of a blood test for the early detection of ovarian cancer has been announced by the North Shore-Long Island Jewish (LIJ) Research Institute (Huntington, NY) and Correlogic Systems, Inc. More...
(Bethesda, MD, USA).

Correlogic has pioneered the development and application of pattern recognition in disease detection and has developed a first test for ovarian cancer using the hidden patterns approach. The company's work is based on a new approach that looks for subtle changes in protein patterns in blood, rather than an increase in an individual biomarker. To identify these hidden patterns, the company employs artificial intelligence-based computer technology. Over the next two years, researchers will collect blood samples from several hundred women, and these samples will be immediately analyzed to validate the test and provide additional information that may help extend the clinical utility of the test.

"Our goal is to change the outcome of ovarian cancer for thousands of women diagnosed with this disease each year,” said Peter Levine, president of Correlogic Systems. "The collaboration with the North Shore-Long Island Jewish Health System, with its powerful reach and expertise, will contribute importantly to that goal.”



Related Links:
LIJ Research Institute
Correlogic

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.